A 64-year-old man is brought to the emergency department by his family due to progressive … — USMLE Step 3

A 64-year-old man is brought to the emergency department by his family due to progressive lethargy, confusion, and worsening constipation over the past week. He has a history of advanced squamous cell carcinoma of the lung. On physical examination, his temperature is $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), blood pressure is $105/65\text{ mmHg}$ , heart rate is $112\text{/min}$ , and respiratory rate is $16\text{/min}$ . The patient is somnolent but arousable to tactile stimuli. The mucous membranes are exceptionally dry, and skin turgor is diminished. There is no jugular venous distention, and lung fields are clear to auscultation.

Laboratory studies show:
Serum calcium: $15.6\text{ mg/dL}$
Serum phosphorus: $2.1\text{ mg/dL}$
Serum creatinine: $1.2\text{ mg/dL}$ (baseline $0.9\text{ mg/dL}$ )
Intact parathyroid hormone (PTH): $8\text{ pg/mL}$ (Normal: $10-65\text{ pg/mL}$ )

Aggressive intravenous fluid resuscitation with 0.9% sodium chloride is initiated. In addition to continued intravenous fluids, which of the following is the most appropriate pharmacologic intervention?

Intravenous calcitonin and intravenous zoledronic acidAnswer
B
Intravenous furosemide and intravenous pamidronate
C
Intravenous hydrocortisone and intravenous calcitonin
D
Oral cinacalcet and continued intravenous normal saline
E
Subcutaneous denosumab and oral sevelamer

Answer

Intravenous calcitonin and intravenous zoledronic acid.

The correct intervention pairs a fast-acting agent with a long-acting one. Severe hypercalcemia (defined as serum calcium

>14\text{ mg/dL}

) causes profound volume depletion due to calcium-induced nephrogenic diabetes insipidus. Initial management always involves aggressive isotonic saline hydration to restore intravascular volume and promote renal calcium excretion. However, hydration alone is insufficient. Intravenous calcitonin is administered because it acts rapidly (within 4 to 6 hours) to inhibit osteoclast activity and increase renal calcium excretion. Because tachyphylaxis to calcitonin typically develops within 48 hours, a bisphosphonate (such as intravenous zoledronic acid or pamidronate) is given concurrently. Bisphosphonates provide potent, sustained inhibition of osteoclastic bone resorption, though their onset of action is delayed by 48 to 72 hours.

Step-by-Step Solution

Assess the severity and etiology of the hypercalcemia.

The calcium level is greater than

14\text{ mg/dL}

(severe), with a suppressed PTH and low phosphorus in the setting of squamous cell carcinoma, confirming PTH-related peptide (PTHrP) driven hypercalcemia of malignancy.

Severity dictates the urgency of treatment, while the etiology determines the appropriate targeted pharmacotherapy.

Evaluate the patient's current volume status and initial intervention.

The patient is profoundly hypovolemic (tachycardia, dry membranes, acute kidney injury) due to calcium-induced nephrogenic diabetes insipidus, justifying the ongoing aggressive normal saline.

Volume status determines whether adjunct therapies like loop diuretics are safe or contraindicated.

Select the optimal pharmacologic agents to augment fluid therapy.

Calcitonin is chosen for its rapid onset, while zoledronic acid is given simultaneously to provide sustained inhibition of bone resorption.

Saline alone is insufficient for severe hypercalcemia. A fast-acting and a long-acting agent must be combined to bridge the time gap to efficacy.

Key Concept

The acute pharmacologic management of severe hypercalcemia of malignancy (

>14\text{ mg/dL}

) consists of aggressive isotonic saline, a rapid-acting agent (calcitonin), and a long-acting agent (a bisphosphonate). Loop diuretics are avoided unless clinical volume overload develops.

Estimated Time:1m 30s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic